AK112

Clinical trials for AK112 explained in plain language.

Never miss a new study

Get alerted when new AK112 trials appear

Sign up with your email to follow new studies for AK112, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New combo therapy aims to shrink rectal tumors without major surgery

Disease control Not yet recruiting

This study tests whether a short course of radiation followed by a drug called ivonescimab can eliminate tumors in people with a specific type of mid-to-low rectal cancer. About 30 adults who have not had prior treatment will receive radiation for 5 days, then the drug every 3 we…

Matched conditions: AK112

Phase: PHASE2 • Sponsor: Zhejiang Cancer Hospital • Aim: Disease control

Last updated May 17, 2026 04:01 UTC

AK112

Get alerted when new AK112 trials appear

New combo therapy aims to shrink rectal tumors without major surgery